Scholars Central

Conference abstract

Expanding the findings of RV144 to South Africa: P5 initiative

Authors: Glenda Gray

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Novel strategies are being researched to discover vaccines to prevent HIV-1. Non-efficacious preventative vaccine approaches include bivalent recombinant gp120 alone, HIV gene insertion into an Adenovirus 5 (Ad5) virus vector and the DNA prime/ Ad5 boost vaccine regimen. However, in the RV144 study, modest efficacy was demonstrated by the ALVAC-HIV prime/AIDSVAX® B/E gp120 boost regimen conducted in Thailand, which showed around 60% protection at 12 months, but waned to 31.2% efficacy at 3.5 years, is now being investigated as a new clade C ALVAC construct, a new bivalent clade C protein adjuvanted with MF59 with an additional boost and 12 months to augment durability. The HVTN 097 replicated the immunogenicity of the RV144 study in South Africa and demonstrated robust vaccine induced immune responses. HVTN 100, a phase 1/2 study evaluated the clade C regimen in South Africa, to inform the immunological basis to evaluate this regimen in advanced clinical development in the form of an efficacy study. This paper will describe the process and rationale to advance the clinical development of the pox-protein public private partnership HIV vaccine program.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Glenda Gray”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels